The decrease in plasma lactate during dichloroacetate (DCA) treatment is attributed to stimulation of lactate oxidation. To determine whether DCA also inhibits lactate production, we measured glucose metabolism in muscles of fed and fasted rats incubated with DCA and insulin. DCA increased glucose-6-phosphate, an allosteric modifier of glycogen synthase, -50% and increased muscle glycogen synthesis and glycogen content > 25%. Lactate release fell; inhibition of glycolysis accounted for > 80% of the decrease. This was associated with a decrease -in intracellular AMP, but no change in citrate or ATP. When lactate oxidation was increased by raising extracellular lactate, glycolysis decreased (r = -0.91), suggesting that lactate oxidation regulates glycolysis. When muscle lactate production was greatly stimulated by thermal injury, DCA increased glycogen synthesis, normalized glycogen content, and inhibited glycolysis, thereby reducing lactate release. The major effect of DCA on lactate metabolism in muscle is to inhibit glycolysis.
Introduction
Dichloroacetate (DCA)' has been used to lower the blood lactate concentration in humans and experimental animals with lactic acidosis (1) (2) (3) (4) . This effect has been attributed to stimulation of pyruvate dehydrogenase activity, resulting in increased lactic acid oxidation (5) (6) (7) . But, after examining the effects of DCA in hepatectomized dogs with lactic acidosis, Park and Arieff (2) concluded that DCA must have reduced lactate production in extrasplanchnic tissues. More recently, Graf et al. (3) measured muscle lactate concentration and hindlimb arteriovenous lactate differences in dogs with hypoxic lactic acidosis and concluded that DCA increased hepatic lactate extraction and reduced lactate production in skeletal muscle. This implies that DCA inhibits glycolysis in peripheral tissues, yet it was concluded that DCA did not reduce glycolysis in the rat hindquarter perfused without insulin (8) . To identify how DCA affects insulin-stimulated glu- 1 . Abbreviations used in this paper: DCA, dichloroacetate. cose utilization in skeletal muscle, we measured the pathways of glucose metabolism in the presence and absence of DCA. DCA caused an inhibition of glycolysis and a stimulation of glycogen synthesis. The inhibition of glycolysis accounted for > 80% of the measured decrease in muscle lactate release. We also found that raising extracellular lactate can inhibit glycolysis so the effect of DCA does not depend on reducing intracellular lactate. Finally, we examined whether DCA would exert the same metabolic effects when the response ofmuscle to a catabolic condition, thermal injury, included accelerated glycolysis and depressed glycogen synthesis (9) .
Methods
Male Sprague-Dawley rats weighing 180-220 g (Chailes River Breeding Laboratories, Inc., Wilmington, MA) were maintained on a 12-h light/ 12-h dark cycle and allowed free access to water and RMH 1000 rat chow (Agway Country Foods, Agway, Inc., Syracuse, NY) for at least 3 d before being studied. Fasted normal rats and rats with thermal injury and their controls were housed in individual wire-bottomed cages to prevent coprophagia and deprived of food and water for 44 h (10) .
Epitrochlearis muscles were removed after anesthetizing rats with 5 mg of pentobarbital/ 100 g of weight. The muscles were rinsed, blotted, weighed, and placed in individual flasks containing 3 ml of Krebs-Henseleit bicarbonate buffer (pH 7.4), 10 mM glucose, 0.2% albumin, with or without 1 mM DCA. Rubber stoppers were placed and the flasks were gassed through needles for 3 min with 95% 2-5% CO2 and then placed in a rotating 60 cycle/min incubator (370C) for 30 min ofpreincubation.
The muscles were removed, blotted, and transferred to flasks containing 3 ml of the same media plus radiolabeled compounds and insulin as indicated, stoppered, regassed, and incubated for either 30 min or 2 h.
To assess glucose transport, muscles were preincubated for 30 min in glucose-free media containing 10 mU/ml insulin and then transferred to flasks containing fresh media with 10 mM glucose, a tracer amount of 2-deoxy-[U-'4C]glucose (0.2 gM; 10 MCi/mmol glucose) and 10 mU/ ml insulin. After incubating for 30 minutes, the muscles were removed, blotted, homogenized in 1 ml of 10% trichloroacetic acid (TCA), and centrifuged. The radioactivity in the supernatant was determined by liquid scintillation counting with correction for quenching using an external standard. The intracellular radioactivity was calculated using previously determined values of the water content and extracellular volume of the epitrochlearis muscle (10) . Glucose [2-3H] glucose (9) . The formation of 3H20 was measured because it is an index ofthe rate ofglucose phosphorylation ( 11) and corresponds closely to glucose uptake by perfused muscle (12 Glucose uptake was calculated as [5-3H] glucose incorporated into glycogen plus 3H20 formed during glycolysis (9) . Net glycolysis was calculated as the difference between the rate of 3H20 formed and substrate recycling (15) . Substrate cycling was calculated as the difference between the rates of glycogen synthesis from [U-'4C]glucose and [5-3H] glucose (16, 17) . This method yields values (9) similar to those measured in incubated epitrochlearis muscles by Challis et al. (17) who calculated substrate cycling from the 3H/'4C ratio of fructose-1,6-diphosphate.
The effects of DCA on muscle glycogen synthase and phosphorylase activities were measured after incubating in 10 mM glucose, with or without 10 mU/ml insulin for 45 min. Enzyme activities are expressed per milliliter ofmuscle homogenate; the activity ratio ofglycogen synthase (%I) is the ratio of enzyme activity measured without to that measured with 10 mM glucose-6-phosphate (18) . The activity ratio of glycogen phosphorylase (%a) was calculated as the ratio of enzyme activity measured without to that measured with 0.1 M AMP (19) . In separate experiments, muscles incubated under similar conditions were homogenized in 1 ml of 5% perchloric acid and assayed enzymatically for glucose-6-phosphate (20) .
The effects of lactate on glucose and lactate metabolism were assessed in muscles preincubated with 10 mM glucose and 10 mU/ml insulin. The muscles were transferred to flasks with fresh media containing 10 mM glucose, 10 mU/ml insulin, different concentrations of lactate, [5-3H] (14) concentrations were measured. Muscles were incubated with 10 mM glucose, 10 mU/ml insulin with or without 1 mM DCA. In another experiment, muscles were preincubated with 10 mM glucose and 10 mU/ml insulin, and then incubated in the same media with or without 8 mM lactate.
To evaluate the metabolic fate of [2-3H] glucose, lactate, pyruvate, and alanine released by muscle were isolated by adding 2 ml of media to a 4X 0.5-cm column of AG 1-4 X anion exchange resin (Biorad Laboratories, Richmond, CA) and washing the column with 20 ml of H20.
The glycolytic products were eluted with 2 ml of 2 M saline and the radioactivity in these products was determined by scintillation counting.
Radiolabeled chemicals were obtained from New England Nuclear (Boston, MA). Reagent grade chemicals, enzymes and fatty acid, and globulin-free albumin were purchased from Sigma Chemical Co. Results are presented as mean±SEM. A paired t test was used to assess the effects of DCA in incubations of muscles from individual rats. An unpaired t test was used to compare results that were obtained from muscles of rats in different treatment groups or incubated at different concentrations of lactate or insulin. Results were considered significant at P< 0.05.
Results
The effects of 1 mM DCA on the different pathways of insulinmediated glucose metabolism in muscles from fed and fasted rats are shown in Fig. 1 . There was a small (18%), but significant,
Substrate Cycl|rg A decrease in the maximal rate of glucose uptake, but otherwise, DCA did not change insulin-stimulated glucose uptake in muscles of fed and fasted rats ( Fig. 1 A) . A more pronounced change caused by DCA was the increase in glycogen synthesis in muscles from fasted rats at all levels of insulin and in muscles of fed rats when insulin exceeded 500 ;tU/ml ( Fig. 1 B) . The most dramatic effect of DCA was to inhibit net glycolysis. This occurred both with and without insulin ( Fig. 1 C) . The decrease in net glycolysis was accompanied by increased substrate cycling of fructose-1,6-diphosphate to fructose-6-phosphate ( Fig. 1 D) , but this accounted for < 10% ofthe decrease in net glycolysis. In the absence ofinsulin, DCA stimulated glucose oxidation by 40% in muscles of fed rats and about threefold in muscles of fasted rats (Fig. 1  E) . At the maximal concentration of insulin, DCA increased muscle glucose oxidation by 30% in fed rats and about fivefold in fasted rats. Lactate release (Fig. 1 F) was sharply reduced at all concentrations of insulin. In the absence of insulin, it was calculated that glucose oxidation could account for only 5% and 30% ofthe DCA-induced decrease in lactate release from muscles of fed and fasted rats, respectively. In the presence of 10 mU/ ml insulin, DCA decreased muscle lactate release 64% in fed rats (-7.6±0.7 ,umol/g per h; P < 0.01) and 59% (-13.4±0.9
smol/g per h; P < 0.01) in fasted rats. Because glucose oxidation was increased by only 0.5-1.5 ,umol/g per h, > 80% of the decrease in lactate release caused by DCA resulted from inhibition of net glycolysis. To study the mechanism by which DCA reduced glucose uptake at supraphysiologic levels of insulin, glucose transport and phosphorylation were measured in muscles of fasted rats using 2-deoxy-[U-'4C]glucose and [2-3H]glucose (9, 11, 12) . With 10 mU/ml insulin, rates of glucose transport and phosphorylation were the same (Table I) ; when DCA was added, 2-deoxy-[U-'4C]glucose transport was unchanged, but glucose phosphorylation (the rate of 3H20 formed) was decreased 17% after 30 min and 12% after 2 h of incubation. The change at 2 h was accompanied by an increased intracellular concentration of 3H-labeled compounds. Both in the presence and absence of DCA, the quantity of 3H contained in acid-precipitable material and that recovered as lactate, pyruvate, and alanine amounted to < 1% of the total quantity of 3H recovered (data not shown). If the intracellular concentration of [2-3H] glucose-6-phosphate had risen, as would occur if the conversion of glucose-6-phosphate to fructose-6-phosphate were inhibited, the 3H content of glycogen should have increased because DCA stimulated glycogen synthesis (Fig. 1 B) . Because the 3H content ofglycogen did not change with DCA, it is likely that the 3H in the soluble fraction was [2-3H] glucose. Thus, the small inhibition ofmaximal insulinstimulated glucose uptake measured in the presence of DCA (Fig. 1 A) must have been due to impaired glucose phosphorylation.
The increase in muscle glycogen synthesis induced by DCA (Fig. 1 B) has not been reported previously. To determine whether this was accompanied by an increase in glycogen content, muscle glycogen was measured after 2 -h of incubation. In the presence of 10 mU/ml ofinsulin, DCA increased the muscle glycogen content 25% in fed rats and 31% in fasted rats (Table  II ). In the absence of insulin, DCA had no effect on muscle glycogen synthesis (Fig. I B) or glycogen content (Table II) .
To study the mechanism by which DCA increased glycogen synthesis, we measured the activity of muscle glycogen synthase and phosphorylase. DCA did not change either the activation ofglycogen synthase by insulin or the activity of glycogen phosphorylase (Table III) . However, in the presence of insulin, DCA increased the intracellular concentration ofglucose-6-phosphate, an allosteric modifier of glycogen synthase (22) , by -50%.
Because DCA causes a marked decrease in extracellular lactate (1-4), we also measured the concentration-effect relationship between extracellular lactate and insulin-stimulated glucose and lactate metabolism in muscle. In the absence of DCA, the rates of lactate uptake, incorporation into glycogen, and oxidation increased as the extracellular concentration oflactate was raised (Fig. 2) . Fasting greatly reduced the capacity for muscle to utilize extracellular lactate. As the lactate concentration was raised, glycogen synthesis increased 30% and glycolysis decreased.
With feeding, glycolysis was inhibited at a physiologic concentration of lactate (2 mM). In fasted rats, glycolysis was not inhibited until the extracellular lactate concentration exceeded 4 mM. In individual muscles of fed and fasted rats, the rate of glycolysis was inversely proportional to the rate of lactate oxidation (r = -0.91; y = -0.50x + 4.97). These results and those obtained with DCA indicate that a high lactate oxidation rate is closely linked to a reduced rate of glycolysis.
The inhibitory effect of DCA and extracellular lactate on glycolysis could be caused by changes in intracellular ATP, AMP, (Table IV) . There were no significant changes in intracellular ATP or citrate during incubation with DCA or lactate. Intracellular lactate fell 71% with DCA and increased more than twofold when muscles were incubated with 8 mM lactate. Previously, we found that thermal injury stimulated lactate production by inhibiting glycogen synthesis and increasing glycolysis in muscles distant from the site of injury (9) . The results in Fig. 1 suggest that DCA should counteract this response. To examine this possibility, we measured the effects of DCA on insulin-mediated metabolism in muscles of burned rats incubated with a physiologic (2 mM) or supraphysiologic (10 mM) concentration of lactate. The pattern of response to DCA in these muscles differed from that in control muscles. Increasing the concentration of extracellular lactate inhibited insulin-stimulated muscle glycolysis by 46% in normal fasted rats, but it did not inhibit the accelerated glycolysis occurring in muscles of burned rats (Table V) . This difference in glycolytic rates occurred despite the fact that lactate oxidation was increased fivefold in muscles from both groups of rats.
To estimate net lactate production, the sum of the rates of lactate incorporated into glycogen and oxidized were subtracted from two times the rate of glycolysis. Based on this calculation, increasing extracellular lactate from 2 to 10 mM inhibited lactate production from muscles of control rats by 56%. In muscles of burned rats, this effect was partially lost in that the decrease was only 22%. In muscles from both groups of rats, raising extracellular lactate increased the glycogen content of muscles (Table V) .
The addition of DCA to incubated muscles of burned and control rats had four major effects on insulin-stimulated metabolism (Table V) . With 2 mM lactate, DCA increased lactate oxidation, glycogen synthesis, and glycogen content, and it decreased glycolysis in muscles of both groups of rats. With 10 mM lactate, DCA also stimulated lactate oxidation and inhibited glycolysis, but glycogen synthesis and the glycogen content of muscle were increased by DCA only in burned rats. Finally, with 2 mM lactate, DCA decreased net lactate release by 20 ,umol/g per h in muscles of both control and burned rats; inhibition ofglycolysis accounted for -90% of the decrease in both groups of muscles. When muscles were incubated with a supraphysiologic (10 mM) concentration of lactate, the combined actions of DCA to reduce glycolysis and accelerate lactate oxidation led to a net removal of 1.8 ,umol lactate/g per h from the media in control rats; net release of lactate by muscles of burned rats was reduced to only 0.5 ,umol lactate/g per h.
From our previous results linking proteolysis to the stimulation oflactate release (9, 25, 26), we expected that DCA would reduce muscle proteolysis. Neither DCA nor raising extracellular lactate changed the rate of net protein degradation (data not shown).
Discussion
In this study, we have identified important changes in muscle metabolism that pertain to the beneficial effects of DCA in conditions associated with excessive accumulation of lactate (1-4). As expected (7, 8) , DCA stimulated glucose and lactate oxidation in skeletal muscle (Fig. 1 gesting that lactate may, in fact, regulate its own metabolism. However, both DCA treatment, which decreases intracellular lactate (Table IV) , and raising extracellular lactate (Fig. 2) stimulate lactate oxidation, as well as inhibit glycolysis. This suggests that the metabolic changes caused by DCA are dependent upon flux through the tricarboxylic acid cycle rather than the intracellular concentration of lactate. One potential mechanism for this effect would be an increase in intracellular levels of citrate or ATP, or a decrease in the AMP concentration inasmuch as these changes in metabolites decrease the in vitro activity of phosphofructokinase (23, 24) . Incubation with DCA or a high extracellular lactate concentration did reduce intracellular AMP but did not change the ATP or citrate concentrations. Whether this change in intracellular AMP caused the metabolic effects of DCA is uncertain because there was no significant change in the ATP/AMP ratio (24) . Thus, the exact mechanism for the inhibitory effect of DCA on glycolysis remains speculative, but our results indicate that this inhibition is quantitatively the most important effect of the drug on lactate metabolism in skeletal muscle.
We also identified another metabolic change induced by DCA, increased glycogen synthesis in muscle. To examine mechanisms that might explain this, we measured the activities of the enzymes regulating glycogen turnover. DCA did not change the activities of muscle glycogen synthase or phosphorylase nor did it augment the activation of glycogen synthase by insulin. DCA did, however, cause a 50% increase in the intracellular concentration of glucose-6-phosphate. This has been shown to cause allosteric modification of glycogen synthase in muscle (22) and could account for the increase in glycogen synthesis (Fig. 1) . The significance of this was emphasized by the finding that DCA increased the glycogen content of muscle (Table II). Similar metabolic changes were demonstrated when muscle lactate production was stimulated as part ofthe response to thermal injury (Table V) . Compared with control rats, burned rats had a different pattern of muscle glucose and lactate metabolism and a different response to raising extracellular lactate.
In spite ofthis, DCA completely corrected the defect in glycogen synthesis, increased the glycogen content of muscle, and substantially reduced lactate release. Again, decreased lactate release was primarily due to inhibition of glycolysis.
The decrease in insulin-stimulated glucose uptake measured during incubation with DCA ( Fig. 1 ) seemed to be caused by impaired glucose phosphorylation (Table I ). An increase in intracellular glucose-6-phosphate (Table III) could decrease the activity of hexokinase (27) . This could limit insulin-stimulated glucose phosphorylation (Table I ). The fact that glucose-6-phosphate levels are increased despite impaired glucose phosphorylation must mean that DCA inhibited glycolysis to a greater extent than it inhibited glucose phosphorylation.
The physiologic significance ofthe decrease in muscle glucose uptake that we found is unclear because the blood glucose of animals or humans given DCA is unchanged or decreased (1, 2, 8, (28) (29) (30) . The hypoglycemic effect ofDCA has been attributed to direct inhibition of hepatic gluconeogenesis (31, 32) and to decreased net release ofgluconeogenic precursors from peripheral tissues (28, 30, 31, 33) . Diamond et al. (30) used the insulin clamp technique to study the effect of DCA in fasted dogs. They concluded that DCA increased glucose clearance by peripheral tissues when plasma insulin was maintained at 10 ,gU/ml plasma.
Although we found that DCA changed glycogen synthesis, glycolysis and glucose oxidation at all levels of insulin studied, there was no detectable effect on muscle glucose uptake except at supraphysiologic concentrations of insulin. Thus, our results suggest that the increased glucose clearance measured by Diamond et al. (30) occurred in nonmuscle tissues.
Another interesting finding was that lactate can regulate muscle glycolysis and hence its own production. Not only was lactate release diminished in muscle of fed and fasted rats when extracellular lactate was high (Fig. 2) , but in individual muscles, the rate of glycolysis was inversely proportional (r = -0.91 ) to the rate of lactate oxidation. In contrast, the ability of lactate to suppress glycolysis was absent in muscles of rats responding to thermal injury in spite of the increased lactate oxidation (Table  V) . Regardless, in muscles of burned rats, DCA markedly suppressed glycolysis and increased glycogen synthesis at both physiologic and supraphysiologic concentrations ofextracellular lactate.
The importance ofglycogen synthesis from lactate in muscle as a means of regulating the blood lactate concentration is unclear. Studies by McLane and Holloszy (34) and Shiota et al. (12) have demonstrated that skeletal muscle from fed rats can incorporate significant amounts of lactate into glycogen when the extracellular lactate concentration is high. We confirmed this and found that this pathway was depressed by fasting (Fig.  2) . Calculation ofglycogen synthesis using the extracellular specific radioactivity of lactate can underestimate the rate of glycogen synthesis from lactate (12, 34) . Measurement of the intracellular specific radioactivity of pyruvate would be preferable, but to do this accurately in muscles of the size we studied is not possible (35) . Although [I-_4C]lactate was used to avoid the contaminating effect of an influx of labelled carbons from tricarbolylic acid cycle intermediates (36) , it is likely that our measurements of glycogen synthesis from lactate and of lactate oxidation are underestimated because glycolysis would dilute the intracellular lactate specific activity. Regardless, this would not affect our interpretation of the metabolic effects of lactate on glucose metabolism.
Previously, we found that the rate of muscle protein degradation was positively correlated with the ratio ofglycolysis (or lactate release) to glucose uptake in muscles of normal rats and rats responding to catabolic conditions (9, 25, 26) . DCA did not significantly change the rate of muscle protein degradation even though it sharply reduced this ratio. This suggests that neither increased glycolysis nor depressed glycogen synthesis account for the accelerated proteolysis associated with the response to thermal injury or uremia. The resuits with DCA do not eliminate the possibility that in these conditions there is a common signal affecting carbohydrate and protein metabolism independently.
In conclusion, our results indicate that the most important effects of DCA on muscle glucose metabolism are to decrease glycolysis and augment insulin-stimulated glycogen synthesis. Based on this, DCA might prove useful in catabolic states by replenishing muscle glycogen stores, increasing the efficiency of glucose utilization, and increasing the responsiveness of muscle to the metabolic effects ofinsulin. However, the drug also inhibits fatty acid and ketone body oxidation and branched-chain amino acid transamination in muscle (7, 37) . To determine whether DCA exerts a net beneficial effect in catabolic conditions, additional studies will be necessary.
